Carson Wealth (CWM LLC)’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25K Buy
52
+34
+189% +$887 ﹤0.01% 5367
2025
Q4
$0 Sell
18
-42
-70% -$442 ﹤0.01% 5461
2025
Q3
$1K Buy
60
+1
+2% +$11 ﹤0.01% 5124
2025
Q2
$1K Buy
59
+19
+48% +$181 ﹤0.01% 5002
2025
Q1
$0 Buy
40
+29
+264% +$352 ﹤0.01% 5109
2024
Q4
$0 Sell
11
-19
-63% -$254 ﹤0.01% 4997
2024
Q3
$0 Buy
+30
New +$445 ﹤0.01% 4940

Other funds holding GLSI

Carson Wealth (CWM LLC)'s GLSI Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Greenwich LifeSciences (GLSI) stake by 189% in Q1 2026, buying an estimated $887 and bringing the position to 52 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #5367.

Carson Wealth (CWM LLC) first reported a position in GLSI in Q3 2024 and has held it in 7 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Carson Wealth (CWM LLC) held 52 shares of Greenwich LifeSciences worth $1.25K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 34 Greenwich LifeSciences shares in Q1 2026, an estimated $887.
  • Greenwich LifeSciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5367 holding.
  • Carson Wealth (CWM LLC) first reported a position in Greenwich LifeSciences in Q3 2024 and has held it in 7 quarters since.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.